首页> 外文期刊>Innovation and Development >Intellectual property protection, regulation and innovation in developing economies: the case of the Indian pharmaceutical industry
【24h】

Intellectual property protection, regulation and innovation in developing economies: the case of the Indian pharmaceutical industry

机译:发展中国家的知识产权保护,法规和创新:以印度制药业为例

获取原文
获取原文并翻译 | 示例
       

摘要

Historically, nations have modified their IP policies to support their development agenda. With the advent of TRIPS, the ability of countries to choose between different IP policy options has reduced considerably but some flexibility remains. Countries have tried to utilize this flexibility for their advantage but in certain respects the choices are difficult. In recent years, certain elements of the new IP regime in India have been vigorously debated in the context of the TRIPS mandated IP policy changes. Given the complex interface between economic development and IP regimes, a variety of arguments have been deployed to argue in favour or against these elements. The paper argues that an evaluation of the IP regime and regulation in developing countries needs to be done in the context of how they facilitate capability building especially through participation of domestic firms in global R&D and production networks. Opportunities for domestic firms to participate in global networks depend on a variety of inter-related factors like emerging technology regimes, changes in global industrial structures, strategies followed by MNCs and capabilities and strategies of domestic firms with respect to innovation. Consequently, the fine-tuning of the IP regime would require an understanding of these developments as well, often in the context of a specific sector. The paper uses this broad heuristic framework to analyze emerging IP policy needs for the Indian pharmaceutical sector and the role of other types of regulation. In the process it also provides some insights on how developing countries with decent technological capabilities can exploit regulatory flexibilities available in the post-TRIPS scenario.View full textDownload full textRelated var addthis_config = { ui_cobrand: "Taylor & Francis Online", services_compact: "citeulike,netvibes,twitter,technorati,delicious,linkedin,facebook,stumbleupon,digg,google,more", pubid: "ra-4dff56cd6bb1830b" }; Add to shortlist Link Permalink http://dx.doi.org/10.1080/2157930X.2011.551050
机译:从历史上看,各国已经修改了其知识产权政策以支持其发展议程。随着《与贸易有关的知识产权协议》的出现,各国在不同的知识产权政策选择之间进行选择的能力已大大降低,但仍具有一定的灵活性。各国试图利用这种灵活性来获得优势,但是在某些方面,选择是困难的。近年来,在《与贸易有关的知识产权协议》(TRIPS)要求对知识产权政策进行修改的背景下,印度对新的知识产权制度的某些要素进行了激烈的辩论。考虑到经济发展与知识产权制度之间的复杂联系,人们已经提出了各种各样的论据来支持或反对这些要素。该论文认为,需要在发展中国家如何促进能力建设的背景下对发展中国家的知识产权制度和法规进行评估,特别是通过国内公司参与全球研发和生产网络来促进能力建设。国内公司参与全球网络的机会取决于各种相互关联的因素,例如新兴技术体系,全球产业结构的变化,跨国公司遵循的战略以及国内公司在创新方面的能力和策略。因此,通常在特定部门的背景下,对知识产权制度的微调也需要了解这些发展。本文使用这种广泛的启发式框架来分析印度制药行业新兴的知识产权政策需求以及其他类型法规的作用。在此过程中,它还提供了一些关于具有良好技术能力的发展中国家如何利用TRIPS后情景中可用的监管灵活性的见解。查看全文下载全文,netvibes,twitter,technorati,可口,linkedin,facebook,stumbleupon,digg,google,更多”,发布:“ ra-4dff56cd6bb1830b”};添加到候选列表链接永久链接http://dx.doi.org/10.1080/2157930X.2011.551050

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号